Black Rock Inc. Prelude Therapeutics Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Black Rock Inc. holds 1,068,916 shares of PRLD stock, worth $790,997. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,068,916
Previous 1,097,474
2.6%
Holding current value
$790,997
Previous $5.2 Million
21.72%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PRLD
# of Institutions
59Shares Held
30.4MCall Options Held
6.4KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$8.07 Million0.38% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$7.49 Million0.14% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.03MShares$761,6070.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$747,6900.0% of portfolio
-
Jacobs Levy Equity Management, Inc Florham Park, NJ667KShares$493,2640.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $26.9M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...